Get In Touch: info@alexareports.com
Contact Us: +1-408-844-4624
Legal Marijuana Market by Type (Medical, Recreational) Product (Oil, Buds, Tinctures) Application (Mental Disorders, Chronic Pain, Cancer, Others) - Global Industry Analysis & Forecast to 2025 Industry Outlook and Trend Analysis The Legal Marijuana Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Growing legalization in different nations is fundamentally driving the market. Besides, rising reception of cannabis as a restorative item for treating conditions, for example, cancer, Parkinson's disease, joint pain, and neurological issue is additionally expected to fuel income development in the following years.
Request for a Sample of this Report @ https://www.alexareports.com/report-sample/41061
Drivers and Restraints Expanding disease outbreaks of incessant pain and developing requirement for viable pain management cures on the worldwide scale is anticipated to enhance the interest for legitimate cannabis. Correspondingly, high predominance of disease is foreseen to be one of the components driving the interest.
Regional Insights North America is anticipated to remain the leading market. In any case, the legitimization in European countries, joined by stringent principles and guidelines with respect to the deal and cultivation, may limit the general development in Europe and thus for the worldwide market.
North America: U.S., Canada, Mexico Europe: Germany, UK, France, Russia, Italy, Rest of Europe Asia-Pacific: China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific South America: Brazil, Argentina, Columbia, Rest of South America Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
Competitive Analysis The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry. Aphria, Inc,Maricann Group Inc., GW Pharmaceuticals, plc., United Cannabis Corporation, Cannabis Sativa, Inc., Canopy Growth Corporation., Aurora Cannabis, Tilray, Lexaria Corp, Tikun Olam Ltd.